Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Vulvar Neoplasms 1Vulvar Diseases 1Uterine Cervical Dysplasia 1Recurrence 1Peritoneal Neoplasms 1Papillomavirus Infections 1Ovarian Neoplasms 1Ovarian Diseases 1Neoplasms, Glandular and Epithelial 1Neoplasms 1Immunologic Deficiency Syndromes 1Glioblastoma 1Genital Neoplasms, Female 1Fallopian Tube Neoplasms 1Epstein-Barr Virus Infections 1Cytomegalovirus Infections 1Carcinoma, Transitional Cell 1Carcinoma, Renal Cell 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1Carcinoma in Situ 1Adenoviridae Infections 1Abdominal Neoplasms 1

Interventions

Paclitaxel 8Hyperthermic Intraperitoneal Chemotherapy 6Mitomycin 5Cisplatin 5Fluorouracil 4Bevacizumab 4Oxaliplatin 3Leucovorin 3Doxorubicin 3Cytoreduction Surgical Procedures 3Carboplatin 3Blood Specimen Collection 3sodium thiosulfate 2pembrolizumab 2Standard of Care 2Laparoscopy 2soluble LAG-3 protein, human 1relacorilant 1oregovomab 1olaparib 1nilotinib 1liposomal doxorubicin 1irinotecan sucrosofate 1dehydroftorafur 1avelumab 1X-Rays 1Topotecan 1Taxes 1Specimen Handling 1Saline Solution 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Peritoneal Neoplasms × Cell Count × 1 year × Clear all
NCT05617755 2025-07-30

AB-1015, an Integrated Circuit T (ICT) Cell Therapy in Patients With Platinum Resistant Epithelial Ovarian Cancer

Arsenal Biosciences, Inc.

Phase 1 Active not recruiting
19 enrolled
Gynecologic

Abdominal Neoplasms, Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Genital Neoplasms, Female, Neoplasms, Glandular and Epithelial, Ovarian Diseases, Ovarian Neoplasms, Peritoneal Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡